Michael Zbonikowski

Key Changes in China’s Export Control Landscape for Rare Earths

par Christoph Hezel et Dr. Jingjing Cao, LL.M. (MUC)

Proposed Amendments to the EU Medical Device Regulation

par Bartosz Świdrak

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

par Irina Rebin

Impact of the new Biotech Act on Clinical Trials in the EU

par Irina Rebin

Life Sciences Legal Lens – Vol. 1

Hungary opens health data infrastructure for AI development

par János Kopasz, AIGP, CIPP/E, CIPM

Promotional activities for medical devices may qualify as agency even without direct negotiation power

par Annabelle Lebaudy

No claim for damages as a result of participation in clinical drug trials

par Irina Rebin

Ban on “social egg freezing” declared unconstitutional

par Christopher Bakier

Request for a Preliminary Ruling by Federal Court of Justice on the Prohibition of Advertising for Remote Medical Treatments under Section 9 HWG

par Dr. Daniel Tietjen et Daniel Dietrich